Activated Carbons for Medical Applications. In vitro Microparticle Characterization and Solute Adsorption

References

• Yatzidis. H. “A Convenient Haemoperfusion Micro-Apparatus Over Charcoal for the Treatment of Endogenous and Exogenous Intoxications,”. Proc. Eur. Dial. Transplant Assoc. 1964; 1: 83
   Google Scholar
• Dunea. G, Kolff W. J. “Clinical Experience With the Yatzidis Charcoal Artificial Kidney,”. Trans. Amer. Soc. Art. Int. Org. 1965; 11: 178
   PubMedGoogle Scholar
• Chang T. M. S. “Semipermeable Microcapsules,”. Science 1964; 146: 524
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Artificial Cells. Springfield, Illinois, Thomas 1972
   Google Scholar
• Chang T. M. S. “Semipermeable Aqueous Microcapsules (Artificial Cells): With Emphasis on Experiments in an Extracorporeal Shunt System,”. Trans. Amer. Soc. Art. Int. Org. 1966; 12: 13
   PubMedGoogle Scholar
• Chang T. M. S., Pont A., Johnson L. J., Malave N. “Response to Intermittent Extracorporeal Perfusion through Shunts Containing Semipermeable Microcapsules,”. Ibid. 1968; 14: 163
   Google Scholar
• Chang T. M. S., Johnson L. J., Ransome O. J. “Semipermeable Aqueous Microcapsules. IV. Nonthrombogenic Microcapsules with Heparin-Complexed Membranes,”. Can. J. Physiol. Pharmacol. 1967; 45: 705
   PubMed Web of Science ®Google Scholar
• Chang T. M. S., Malave. N. “The Development and First Clinical Use of Semipermeable Microcapsules (Artificial Cells) as a Compact Artificial Kidney,”. Trans. Amer. Soc. Art. Int. Org. 1970; 16: 141
   PubMedGoogle Scholar
• Chang T. M. S., Gonda. A, Dirks J. H., Malave. N. “Clinical Evaluation of Chronic, Intermittent, and Short Term Hemoperfusions in Patients with Chronic Renal Failure Using Semipermeable Microcapsules (Artificial Cells) Formed from Membrane-Coated Activated Charcoal,”. Ibid. 1971; 17: 246
   Google Scholar
• Chang T. M. S., Gonda. A, Dirks J. H., Coffey J. F., Burns T. L. “ACAC Microcapsule Artificial Kidney for the Long Term and Short Term Management of Eleven Patients With Chronic Renal Failure,”. Ibid. 1972; 18: 465
   Google Scholar
• Chang T. M. S. “Microcapsule Artificial Kidney and Medium Molecular Weight Clearance,”. Proc. Eur. Dial. Transplant Assoc. 1972; 8: 568
   Google Scholar
• Andrade J. D., Kunitomo. K, Van Wagenen R., Kastigar. B, Gough. D, Kolff W. J. “Coated Adsorbents for Direct Blood Perfusion: Hema/Activated Carbon,”. Trans. Amer. Soc. Art. Int. Org. 1971; 17: 222
   PubMedGoogle Scholar
• Andrade J. D., Van Wagenen R., Chen. C, Ghavamian. M, Volder J. G. R., Kirkham. R, Kolff W. J. “Coated Adsorbents for Direct Blood Perfusion II,”. Ibid. 1972; 18: 473
   Google Scholar
• Yatzidis. H. “The Charcoal Kidney in Clinical Practice,”. a Paper Presented at the Cleveland Clinic. Cleveland, Ohio October 18, 1966
   Google Scholar
• Yatzidis. H, Oreopoulos. D, Triantaphyllidis. D, Vaudiclari. S, Tsaparas. N, Gavras. G, Stavrovlakis. A. “Treatment of Severe Barbiturate Poisoning,”. Lancet 1965; 2: 216
   PubMed Web of Science ®Google Scholar
• De Myttenaere M. H., Maher J. F., Schreiner G. E. “Hemoperfusion through a Charcoal Column for Glutethimide Poisoning,” Trans. Amer. Soc. Art. Int. Org. 1967; 13: 190
   Google Scholar
• De Myttenaere M. “Haemoperfusion through a Charcoal Column for Treatment of Poisoning,”. Proc. Eur. Dial. Transplant Assoc. 1968; 5: 320
   Google Scholar
• Rosenbaum J. L., Ronquillo. E, Argyres S. N. “Column Hemoperfusion and Hemodialysis Techniques to Treat Barbiturate Intoxication in Dogs,”. J. Albert Einstein Med. Cent. 1968; 16: 67
   Google Scholar
• Chang T. M. S., Coffey J. F., Barre. P, Gonda. A, Dirks J. H., Levy. M, Lister. C. “Microcapsule Artificial Kidney: Treatment of Patients with Acute Drug Intoxication,”. Can. Med. Assoc. J. 1973; 108: 429
   PubMed Web of Science ®Google Scholar
• Chang T. M. S., Coffey J. F., Lister. C, Taroy. E, Stark. A. “Methaqualone, Methyprylon, and Glutethimide Clearance by the ACAC Microcapsule Artificial Kidney: In vitro and in Patients with Acute Intoxication,”. Trans. Amer. Soc. Art. Int. Org. 1973; 19: 87
   PubMedGoogle Scholar
• Final Report on Contract #PH-43-68-1027, U.S. Public Health Service, National Institute of Arthritis and Metabolic Diseases, Artificial Kidney-Chronic Uraemia Program. W. J. Kolff, Principal Investigator, March 1973
   Google Scholar
• Hagstam K. E., Larsson L. E., Thysell. H. “Experimental Studies on Charcoal Hemoperfusion in Phenobarbital Intoxication and Uremia, Including Histopathological Findings,”. Acta Med. Scand. 1966; 180: 593
   PubMed Web of Science ®Google Scholar
• Andrade J. D., Kopp. K, Van Wagenen R., Chen. C, Kolff W. J. “Activated Carbon and Blood Perfusion: A Critical Review,”. Proc. Eur. Dial. Transplant Assoc. 1972; 9: 290
   PubMedGoogle Scholar
• Merrill J. P. “Treatment of Drug Intoxication by Hemoperfusion,”. New Eng. J. Med. 1971; 284: 911
   PubMedGoogle Scholar
• Basic Concepts of Adsorption on Activated Carbon (a brochure), Pittsburgh Activated Carbon Division of Calgon Corporation. subsidiary of Merck & Co., Inc., Pittsburgh, Pennsylvania, 15230, Calgon Center, Box 1346
   Google Scholar
• Brunauer. S, Emmett P. H., Teller. E. “Adsorption of Gases in Multimolecular Layers,”. J. Amer. Chem. Soc. 1938; 60: 309
   Web of Science ®Google Scholar